Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00980057 · ClinicalTrials.gov registry record · NA
Adaptive Cardiac Resynchronization Therapy Study
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 522
- Enrollment target
NCT00980057 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 522 participants.
The verdict
NCT00980057, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 522 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the AdaptivCRT algorithm is at least as good as manual echo based optimization in regard to patient outcomes and cardiac performance
Interventions
- DEVICE Adaptive CRT (aCRT)
- DEVICE Echo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 522 participants |
| Start Date | 2009-10-01 |
| Est. Completion | 2012-03-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00980057
The ClinicalTrials.gov registry entry for NCT00980057 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 522 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Adaptive CRT (aCRT) is the first listed.
NCT00980057 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00980057 about?
NCT00980057 is a clinical study titled "Adaptive Cardiac Resynchronization Therapy Study". The purpose of this study is to demonstrate the AdaptivCRT algorithm is at least as good as manual echo based optimization in regard to patient outcomes and cardiac performance
What is the current status of trial NCT00980057?
This trial is currently completed. It is a NA study. The enrollment target is 522 participants. The study started on 2009-10-01. Estimated completion is 2012-03-08.
What interventions are being tested in trial NCT00980057?
The interventions under investigation include: Adaptive CRT (aCRT) (DEVICE), Echo (DEVICE).
Who is sponsoring clinical trial NCT00980057?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.